Genome Medicine (Jun 2022)
Gain and loss of TASK3 channel function and its regulation by novel variation cause KCNK9 imprinting syndrome
- Margot A. Cousin,
- Emma L. Veale,
- Nikita R. Dsouza,
- Swarnendu Tripathi,
- Robyn G. Holden,
- Maria Arelin,
- Geoffrey Beek,
- Mir Reza Bekheirnia,
- Jasmin Beygo,
- Vikas Bhambhani,
- Martin Bialer,
- Stefania Bigoni,
- Cyrus Boelman,
- Jenny Carmichael,
- Thomas Courtin,
- Benjamin Cogne,
- Ivana Dabaj,
- Diane Doummar,
- Laura Fazilleau,
- Alessandra Ferlini,
- Ralitza H. Gavrilova,
- John M. Graham,
- Tobias B. Haack,
- Jane Juusola,
- Sarina G. Kant,
- Saima Kayani,
- Boris Keren,
- Petra Ketteler,
- Chiara Klöckner,
- Tamara T. Koopmann,
- Teresa M. Kruisselbrink,
- Alma Kuechler,
- Laëtitia Lambert,
- Xénia Latypova,
- Robert Roger Lebel,
- Magalie S. Leduc,
- Emanuela Leonardi,
- Andrea M. Lewis,
- Wendy Liew,
- Keren Machol,
- Samir Mardini,
- Kirsty McWalter,
- Cyril Mignot,
- Julie McLaughlin,
- Alessandra Murgia,
- Vinodh Narayanan,
- Caroline Nava,
- Sonja Neuser,
- Mathilde Nizon,
- Davide Ognibene,
- Joohyun Park,
- Konrad Platzer,
- Céline Poirsier,
- Maximilian Radtke,
- Keri Ramsey,
- Cassandra K. Runke,
- Maria J. Guillen Sacoto,
- Fernando Scaglia,
- Marwan Shinawi,
- Stephanie Spranger,
- Ee Shien Tan,
- John Taylor,
- Anne-Sophie Trentesaux,
- Filippo Vairo,
- Rebecca Willaert,
- Neda Zadeh,
- Raul Urrutia,
- Dusica Babovic-Vuksanovic,
- Michael T. Zimmermann,
- Alistair Mathie,
- Eric W. Klee
Affiliations
- Margot A. Cousin
- Department of Quantitative Health Sciences, Mayo Clinic
- Emma L. Veale
- Medway School of Pharmacy, University of Kent and University of Greenwich, Central Avenue, Anson Building, Central Avenue, Chatham Maritime
- Nikita R. Dsouza
- Bioinformatics Research and Development Laboratory, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin
- Swarnendu Tripathi
- Bioinformatics Research and Development Laboratory, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin
- Robyn G. Holden
- Medway School of Pharmacy, University of Kent and University of Greenwich, Central Avenue, Anson Building, Central Avenue, Chatham Maritime
- Maria Arelin
- Department for Women and Child Health, Hospital for Children and Adolescents, University Hospitals, University of Leipzig
- Geoffrey Beek
- Children’s Hospital of Minnesota
- Mir Reza Bekheirnia
- Department of Molecular and Human Genetics, Baylor College of Medicine
- Jasmin Beygo
- Institute of Human Genetics, University Hospital Essen, University of Duisburg-Essen
- Vikas Bhambhani
- Children’s Hospital of Minnesota
- Martin Bialer
- Division of Medical Genetics, Northwell Health
- Stefania Bigoni
- Medical Genetics Unit, Department of Medical Sciences, Ferrara University
- Cyrus Boelman
- Division of Neurology, BC Children’s Hospital
- Jenny Carmichael
- Oxford Centre for Genomic Medicine, ACE Building, Nuffield Orthopaedic centre, Oxford University Hospitals NHS Foundation Trust
- Thomas Courtin
- Département of Genetics, APHP, Hôpital Pitié-Salpêtrière, Sorbonne Université
- Benjamin Cogne
- CHU Nantes, Service de génétique médicale
- Ivana Dabaj
- CHU de Rouen, Service de Néonatologie, Réanimation pédiatrique, Neuropédiatrie et éducation fonctionnelle de l’enfant, INSERM U 1245, ED497
- Diane Doummar
- APHP, Department of Neuropediatrics, National Reference Center for Neurogenetic Disorders, Hôpital Armand-Trousseau, GHUEP
- Laura Fazilleau
- Service de Néonatologie, CHU de Caen
- Alessandra Ferlini
- Medical Genetics Unit, Department of Medical Sciences, Ferrara University
- Ralitza H. Gavrilova
- Center for Individualized Medicine, Mayo Clinic
- John M. Graham
- Department of Pediatrics, Harbor-UCLA Medical Center, Cedars-Sinai Medical Center, David Geffen School of Medicine at UCLA
- Tobias B. Haack
- Centre for Rare Diseases, University of Tübingen
- Jane Juusola
- GeneDx
- Sarina G. Kant
- Department of Clinical Genetics, Leiden University Medical Center
- Saima Kayani
- Departments of Pediatrics and Neurology, University of Texas Southwestern Medical Center and Children’s Health
- Boris Keren
- APHP, Département de Génétique et Centre de Référence Déficiences Intellectuelles de Causes Rares, Hôpital de la Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris
- Petra Ketteler
- Institute of Human Genetics, University Hospital Essen, University of Duisburg-Essen
- Chiara Klöckner
- Institute of Human Genetics, University of Leipzig Medical Center
- Tamara T. Koopmann
- Department of Clinical Genetics, Leiden University Medical Center
- Teresa M. Kruisselbrink
- Center for Individualized Medicine, Mayo Clinic
- Alma Kuechler
- Institute of Human Genetics, University Hospital Essen, University of Duisburg-Essen
- Laëtitia Lambert
- Service de Genetique Clinique, CHRU de Nancy
- Xénia Latypova
- CHU Nantes, Service de génétique médicale
- Robert Roger Lebel
- Section of Medical Genetics, SUNY Upstate University Hospital
- Magalie S. Leduc
- Department of Molecular and Human Genetics, Baylor College of Medicine
- Emanuela Leonardi
- Molecular Genetics of Neurodevelopmental Disorders, Department of Woman and Child Health, University of Padova
- Andrea M. Lewis
- Department of Molecular and Human Genetics, Baylor College of Medicine
- Wendy Liew
- Department of Paediatric Medicine, KK Women’s and Children’s Hospital, Mount Elizabeth Hospital
- Keren Machol
- Department of Molecular and Human Genetics, Baylor College of Medicine
- Samir Mardini
- Division of Plastic and Reconstructive Surgery, Mayo Clinic
- Kirsty McWalter
- GeneDx
- Cyril Mignot
- APHP, Département de Génétique et Centre de Référence Déficiences Intellectuelles de Causes Rares, Hôpital de la Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris
- Julie McLaughlin
- Division of Medical Genetics, Northwell Health
- Alessandra Murgia
- Molecular Genetics of Neurodevelopmental Disorders, Department of Woman and Child Health, University of Padova
- Vinodh Narayanan
- Center for Rare Childhood Disorders, Translational Genomics Research Institute
- Caroline Nava
- APHP, Département de Génétique et Centre de Référence Déficiences Intellectuelles de Causes Rares, Hôpital de la Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris
- Sonja Neuser
- Institute of Human Genetics, University of Leipzig Medical Center
- Mathilde Nizon
- CHU Nantes, Service de génétique médicale
- Davide Ognibene
- Medical Genetics Unit, Department of Medical Sciences, Ferrara University
- Joohyun Park
- Institute of Medical Genetics and Applied Genomics, University of Tübingen
- Konrad Platzer
- Institute of Human Genetics, University of Leipzig Medical Center
- Céline Poirsier
- Department of Genetics, Reims University Hospital
- Maximilian Radtke
- Institute of Human Genetics, University of Leipzig Medical Center
- Keri Ramsey
- Center for Rare Childhood Disorders, Translational Genomics Research Institute
- Cassandra K. Runke
- Department of Clinical Genomics, Mayo Clinic
- Maria J. Guillen Sacoto
- GeneDx
- Fernando Scaglia
- Department of Molecular and Human Genetics, Baylor College of Medicine
- Marwan Shinawi
- Department of Pediatrics, Division of Genetics and Genomic Medicine, Washington University School of Medicine
- Stephanie Spranger
- Practice of Human Genetics
- Ee Shien Tan
- Department of Paediatric Medicine, KK Women’s and Children’s Hospital, Mount Elizabeth Hospital
- John Taylor
- Oxford Centre for Genomic Medicine, ACE Building, Nuffield Orthopaedic centre, Oxford University Hospitals NHS Foundation Trust
- Anne-Sophie Trentesaux
- Service de Néonatologie, CHU de Caen
- Filippo Vairo
- Center for Individualized Medicine, Mayo Clinic
- Rebecca Willaert
- GeneDx
- Neda Zadeh
- Genetics Center
- Raul Urrutia
- Bioinformatics Research and Development Laboratory, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin
- Dusica Babovic-Vuksanovic
- Center for Individualized Medicine, Mayo Clinic
- Michael T. Zimmermann
- Bioinformatics Research and Development Laboratory, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin
- Alistair Mathie
- Medway School of Pharmacy, University of Kent and University of Greenwich, Central Avenue, Anson Building, Central Avenue, Chatham Maritime
- Eric W. Klee
- Department of Quantitative Health Sciences, Mayo Clinic
- DOI
- https://doi.org/10.1186/s13073-022-01064-4
- Journal volume & issue
-
Vol. 14,
no. 1
pp. 1 – 19
Abstract
Abstract Background Genomics enables individualized diagnosis and treatment, but large challenges remain to functionally interpret rare variants. To date, only one causative variant has been described for KCNK9 imprinting syndrome (KIS). The genotypic and phenotypic spectrum of KIS has yet to be described and the precise mechanism of disease fully understood. Methods This study discovers mechanisms underlying KCNK9 imprinting syndrome (KIS) by describing 15 novel KCNK9 alterations from 47 KIS-affected individuals. We use clinical genetics and computer-assisted facial phenotyping to describe the phenotypic spectrum of KIS. We then interrogate the functional effects of the variants in the encoded TASK3 channel using sequence-based analysis, 3D molecular mechanic and dynamic protein modeling, and in vitro electrophysiological and functional methodologies. Results We describe the broader genetic and phenotypic variability for KIS in a cohort of individuals identifying an additional mutational hotspot at p.Arg131 and demonstrating the common features of this neurodevelopmental disorder to include motor and speech delay, intellectual disability, early feeding difficulties, muscular hypotonia, behavioral abnormalities, and dysmorphic features. The computational protein modeling and in vitro electrophysiological studies discover variability of the impact of KCNK9 variants on TASK3 channel function identifying variants causing gain and others causing loss of conductance. The most consistent functional impact of KCNK9 genetic variants, however, was altered channel regulation. Conclusions This study extends our understanding of KIS mechanisms demonstrating its complex etiology including gain and loss of channel function and consistent loss of channel regulation. These data are rapidly applicable to diagnostic strategies, as KIS is not identifiable from clinical features alone and thus should be molecularly diagnosed. Furthermore, our data suggests unique therapeutic strategies may be needed to address the specific functional consequences of KCNK9 variation on channel function and regulation.
Keywords
- KCNK9 imprinting syndrome
- TASK3 channel
- Neurodevelopmental disorder
- Electrophysiology
- Computational protein modeling